Tuesday, June 17, 2025
wellness India Expo
Home Tags Lynparza

Tag: Lynparza

DCGI approves AstraZeneca’s Lynparza as a monotherapy for high-risk early breast...

Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer